Nanomedicine for the management of rheumatoid arthritis: current status and prospective therapeutic approaches - Pharma Excipients

Approximately 18 million people around the world suffer from rheumatoid arthritis. And, although this condition is chronic, researchers have developed a new treatment against this autoimmune disease. It will increase the life expectancy of millions of affected CIBER-BBN and CIBERES researchers, at the Institute of Polymer Science and Technology and the Institute of Medical Chemistry have developed an innovative treatment for arthritis. It will h…

Nanomedicine for the management of rheumatoid arthritis: current status and prospective therapeutic approaches - Pharma Excipients

Abstract Nanotechnology has rapidly become a viable instrument for investigating innovative methods, ranging from properly identifying many disorders to treating intricate medical situations. Due to their adjustable surface qualities and similar size dimensions, custom-designed nanoparticles can now interact with cellular targets and diverse diseases more effectively. The primary objective of medicine distribution is to guarantee that pharmaceut…